Cell Line Development | CAGR 12% by 2021 | GE Healthcare, Lonza, Merck Millipore, and Thermo Fisher Scientific
Press Release - 19 Mar 2018
Global Research and Development News --
. .
Report Description-
' '
Cell line development is the process by which prokaryotic (bacteria, virus, protozoa) and eukaryotic (animals, plants) cells are allowed to grow under precise conditions. But in practice, cell line development is generally derived from animal cells which includes mammals, insects and amphibians. The cells are removed from tissue and separated through enzymatic or mechanical process which is further used for cultivation.
– Get Sample Report https://www.researchmoz.us/enquiry.php?type=S&repid=1217052
' '
Technavios analysts forecast the global cell line development market to grow at a CAGR of 12.27% during the period 2017-2021.
– Covered in this report
The report covers the present scenario and the growth prospects of the global cell line development market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sale of cell line development system.
– The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavio's report, Global Cell Line Development Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
– Key vendors
GE Healthcare
Lonza
Merck Millipore
Thermo Fisher Scientific
– Other prominent vendors
Cobra Biologics
Corning
Molecular Devices
sartorious
SELEXIS
WuXi Biologics
– Market driver
Increased demand for monoclonal antibodies
For a full, detailed list, view our report
– Market challenge
Development of authentic cell lines
For a full, detailed list, view our report
– Market trend
Increase demand for regenerative medicine
For a full, detailed list, view our report
– Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
. .
– More Clear Details get Table of Contents https://www.researchmoz.us/global-cell-line-development-market-2017-2021-report.html/toc
..
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
Market outline
PART 05: Market landscape
Market size and forecast
Five forces analysis
PART 06: Market segmentation by product
Global cell line development market by product type
Global cell line development market by media and reagents
Global cell line development market by equipment
PART 07: Geographical segmentation
Global cell line development market by geography
Cell line development market in Americas
Cell line development market in EMEA
Cell line development market in APAC
PART 08: Decision framework
PART 09: Drivers and challenges
Market drivers
Market challenges
PART 10: Market trends
Increase demand for regenerative medicine
Adoption of laboratory automation
Growing prevalence of autoimmune diseases and cancer
PART 11: Vendor landscape
Competitive scenario
Investment opportunity
PART 12: Key vendor analysis
GE Healthcare
Lonza
Merck Millipore
Thermo Fisher Scientific
Other prominent vendors